The global market for LNP-mRNA Therapy was valued at US$ 547 million in the year 2024 and is projected to reach a revised size of US$ 767 million by 2031, growing at a CAGR of 5.6% during the forecast period.

LNP-mRNA Therapy Market

LNP-mRNA Therapy represents a cutting-edge biomedical technology that leverages the unique strengths of Lipid Nanoparticles (LNPs) and Messenger RNA (mRNA) to offer novel treatment avenues for various diseases. Serving as carriers, LNPs effectively shield mRNA from enzymatic degradation in the body and deliver it precisely to target cells. mRNA carries the genetic information necessary for synthesizing specific proteins; once inside cells, it directs the cells to produce these proteins, thereby triggering immune responses or repairing damaged tissues. This therapy demonstrates significant potential in treating cancers, genetic disorders, and infectious diseases. Its highly personalized and rapid-response characteristics have made LNP-mRNA Therapy a research focus in the biomedical field. By precisely regulating gene expression, LNP-mRNA Therapy provides patients with unprecedented treatment options, ushering in a new era of precision medicine.

North American market for LNP-mRNA Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for LNP-mRNA Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for LNP-mRNA Therapy in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of LNP-mRNA Therapy include Genevant Sciences, Moderna, BioNTech, Pfizer, NanoVation Therapeutics, CureVac, Sanofi, Promab, Grand Pharm, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for LNP-mRNA Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding LNP-mRNA Therapy.

The LNP-mRNA Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global LNP-mRNA Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the LNP-mRNA Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of LNP-mRNA Therapy Market Report

Report Metric	Details
Report Name	LNP-mRNA Therapy Market
Accounted market size in year	US$ 547 million
Forecasted market size in 2031	US$ 767 million
CAGR	5.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Passive Targeting Active Targeting
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Genevant Sciences, Moderna, BioNTech, Pfizer, NanoVation Therapeutics, CureVac, Sanofi, Promab, Grand Pharm
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of LNP-mRNA Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is LNP-mRNA Therapy Market growing?

Ans: The LNP-mRNA Therapy Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the LNP-mRNA Therapy Market size in 2031?

Ans: The LNP-mRNA Therapy Market size in 2031 will be US$ 767 million.

Who are the main players in the LNP-mRNA Therapy Market report?

Ans: The main players in the LNP-mRNA Therapy Market are Genevant Sciences, Moderna, BioNTech, Pfizer, NanoVation Therapeutics, CureVac, Sanofi, Promab, Grand Pharm

What are the Application segmentation covered in the LNP-mRNA Therapy Market report?

Ans: The Applications covered in the LNP-mRNA Therapy Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the LNP-mRNA Therapy Market report?

Ans: The Types covered in the LNP-mRNA Therapy Market report are Passive Targeting, Active Targeting

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global LNP-mRNA Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Passive Targeting

1.2.3 Active Targeting

1.3 Market by Application

1.3.1 Global LNP-mRNA Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global LNP-mRNA Therapy Market Perspective (2020-2031)

2.2 Global LNP-mRNA Therapy Growth Trends by Region

2.2.1 Global LNP-mRNA Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 LNP-mRNA Therapy Historic Market Size by Region (2020-2025)

2.2.3 LNP-mRNA Therapy Forecasted Market Size by Region (2026-2031)

2.3 LNP-mRNA Therapy Market Dynamics

2.3.1 LNP-mRNA Therapy Industry Trends

2.3.2 LNP-mRNA Therapy Market Drivers

2.3.3 LNP-mRNA Therapy Market Challenges

2.3.4 LNP-mRNA Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top LNP-mRNA Therapy Players by Revenue

3.1.1 Global Top LNP-mRNA Therapy Players by Revenue (2020-2025)

3.1.2 Global LNP-mRNA Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Top LNP-mRNA Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by LNP-mRNA Therapy Revenue

3.4 Global LNP-mRNA Therapy Market Concentration Ratio

3.4.1 Global LNP-mRNA Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by LNP-mRNA Therapy Revenue in 2024

3.5 Global Key Players of LNP-mRNA Therapy Head office and Area Served

3.6 Global Key Players of LNP-mRNA Therapy, Product and Application

3.7 Global Key Players of LNP-mRNA Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 LNP-mRNA Therapy Breakdown Data by Type

4.1 Global LNP-mRNA Therapy Historic Market Size by Type (2020-2025)

4.2 Global LNP-mRNA Therapy Forecasted Market Size by Type (2026-2031)

5 LNP-mRNA Therapy Breakdown Data by Application

5.1 Global LNP-mRNA Therapy Historic Market Size by Application (2020-2025)

5.2 Global LNP-mRNA Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America LNP-mRNA Therapy Market Size (2020-2031)

6.2 North America LNP-mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America LNP-mRNA Therapy Market Size by Country (2020-2025)

6.4 North America LNP-mRNA Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe LNP-mRNA Therapy Market Size (2020-2031)

7.2 Europe LNP-mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe LNP-mRNA Therapy Market Size by Country (2020-2025)

7.4 Europe LNP-mRNA Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific LNP-mRNA Therapy Market Size (2020-2031)

8.2 Asia-Pacific LNP-mRNA Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific LNP-mRNA Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific LNP-mRNA Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America LNP-mRNA Therapy Market Size (2020-2031)

9.2 Latin America LNP-mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America LNP-mRNA Therapy Market Size by Country (2020-2025)

9.4 Latin America LNP-mRNA Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa LNP-mRNA Therapy Market Size (2020-2031)

10.2 Middle East & Africa LNP-mRNA Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa LNP-mRNA Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa LNP-mRNA Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Genevant Sciences

11.1.1 Genevant Sciences Company Details

11.1.2 Genevant Sciences Business Overview

11.1.3 Genevant Sciences LNP-mRNA Therapy Introduction

11.1.4 Genevant Sciences Revenue in LNP-mRNA Therapy Business (2020-2025)

11.1.5 Genevant Sciences Recent Development

11.2 Moderna

11.2.1 Moderna Company Details

11.2.2 Moderna Business Overview

11.2.3 Moderna LNP-mRNA Therapy Introduction

11.2.4 Moderna Revenue in LNP-mRNA Therapy Business (2020-2025)

11.2.5 Moderna Recent Development

11.3 BioNTech

11.3.1 BioNTech Company Details

11.3.2 BioNTech Business Overview

11.3.3 BioNTech LNP-mRNA Therapy Introduction

11.3.4 BioNTech Revenue in LNP-mRNA Therapy Business (2020-2025)

11.3.5 BioNTech Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer LNP-mRNA Therapy Introduction

11.4.4 Pfizer Revenue in LNP-mRNA Therapy Business (2020-2025)

11.4.5 Pfizer Recent Development

11.5 NanoVation Therapeutics

11.5.1 NanoVation Therapeutics Company Details

11.5.2 NanoVation Therapeutics Business Overview

11.5.3 NanoVation Therapeutics LNP-mRNA Therapy Introduction

11.5.4 NanoVation Therapeutics Revenue in LNP-mRNA Therapy Business (2020-2025)

11.5.5 NanoVation Therapeutics Recent Development

11.6 CureVac

11.6.1 CureVac Company Details

11.6.2 CureVac Business Overview

11.6.3 CureVac LNP-mRNA Therapy Introduction

11.6.4 CureVac Revenue in LNP-mRNA Therapy Business (2020-2025)

11.6.5 CureVac Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi LNP-mRNA Therapy Introduction

11.7.4 Sanofi Revenue in LNP-mRNA Therapy Business (2020-2025)

11.7.5 Sanofi Recent Development

11.8 Promab

11.8.1 Promab Company Details

11.8.2 Promab Business Overview

11.8.3 Promab LNP-mRNA Therapy Introduction

11.8.4 Promab Revenue in LNP-mRNA Therapy Business (2020-2025)

11.8.5 Promab Recent Development

11.9 Grand Pharm

11.9.1 Grand Pharm Company Details

11.9.2 Grand Pharm Business Overview

11.9.3 Grand Pharm LNP-mRNA Therapy Introduction

11.9.4 Grand Pharm Revenue in LNP-mRNA Therapy Business (2020-2025)

11.9.5 Grand Pharm Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

NanoVation Therapeutics

List of Tables

Table 1. Global LNP-mRNA Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Passive Targeting

Table 3. Key Players of Active Targeting

Table 4. Global LNP-mRNA Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global LNP-mRNA Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global LNP-mRNA Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global LNP-mRNA Therapy Market Share by Region (2020-2025)

Table 8. Global LNP-mRNA Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global LNP-mRNA Therapy Market Share by Region (2026-2031)

Table 10. LNP-mRNA Therapy Market Trends

Table 11. LNP-mRNA Therapy Market Drivers

Table 12. LNP-mRNA Therapy Market Challenges

Table 13. LNP-mRNA Therapy Market Restraints

Table 14. Global LNP-mRNA Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global LNP-mRNA Therapy Market Share by Players (2020-2025)

Table 16. Global Top LNP-mRNA Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LNP-mRNA Therapy as of 2024)

Table 17. Ranking of Global Top LNP-mRNA Therapy Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by LNP-mRNA Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of LNP-mRNA Therapy, Headquarters and Area Served

Table 20. Global Key Players of LNP-mRNA Therapy, Product and Application

Table 21. Global Key Players of LNP-mRNA Therapy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global LNP-mRNA Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global LNP-mRNA Therapy Revenue Market Share by Type (2020-2025)

Table 25. Global LNP-mRNA Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global LNP-mRNA Therapy Revenue Market Share by Type (2026-2031)

Table 27. Global LNP-mRNA Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global LNP-mRNA Therapy Revenue Market Share by Application (2020-2025)

Table 29. Global LNP-mRNA Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global LNP-mRNA Therapy Revenue Market Share by Application (2026-2031)

Table 31. North America LNP-mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America LNP-mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America LNP-mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe LNP-mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe LNP-mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe LNP-mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific LNP-mRNA Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific LNP-mRNA Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific LNP-mRNA Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America LNP-mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America LNP-mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America LNP-mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa LNP-mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa LNP-mRNA Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa LNP-mRNA Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Genevant Sciences Company Details

Table 47. Genevant Sciences Business Overview

Table 48. Genevant Sciences LNP-mRNA Therapy Product

Table 49. Genevant Sciences Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)

Table 50. Genevant Sciences Recent Development

Table 51. Moderna Company Details

Table 52. Moderna Business Overview

Table 53. Moderna LNP-mRNA Therapy Product

Table 54. Moderna Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)

Table 55. Moderna Recent Development

Table 56. BioNTech Company Details

Table 57. BioNTech Business Overview

Table 58. BioNTech LNP-mRNA Therapy Product

Table 59. BioNTech Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)

Table 60. BioNTech Recent Development

Table 61. Pfizer Company Details

Table 62. Pfizer Business Overview

Table 63. Pfizer LNP-mRNA Therapy Product

Table 64. Pfizer Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)

Table 65. Pfizer Recent Development

Table 66. NanoVation Therapeutics Company Details

Table 67. NanoVation Therapeutics Business Overview

Table 68. NanoVation Therapeutics LNP-mRNA Therapy Product

Table 69. NanoVation Therapeutics Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)

Table 70. NanoVation Therapeutics Recent Development

Table 71. CureVac Company Details

Table 72. CureVac Business Overview

Table 73. CureVac LNP-mRNA Therapy Product

Table 74. CureVac Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)

Table 75. CureVac Recent Development

Table 76. Sanofi Company Details

Table 77. Sanofi Business Overview

Table 78. Sanofi LNP-mRNA Therapy Product

Table 79. Sanofi Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)

Table 80. Sanofi Recent Development

Table 81. Promab Company Details

Table 82. Promab Business Overview

Table 83. Promab LNP-mRNA Therapy Product

Table 84. Promab Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)

Table 85. Promab Recent Development

Table 86. Grand Pharm Company Details

Table 87. Grand Pharm Business Overview

Table 88. Grand Pharm LNP-mRNA Therapy Product

Table 89. Grand Pharm Revenue in LNP-mRNA Therapy Business (2020-2025) & (US$ Million)

Table 90. Grand Pharm Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

Table 94. Authors List of This Report

List of Figures

Figure 1. LNP-mRNA Therapy Picture

Figure 2. Global LNP-mRNA Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global LNP-mRNA Therapy Market Share by Type: 2024 VS 2031

Figure 4. Passive Targeting Features

Figure 5. Active Targeting Features

Figure 6. Global LNP-mRNA Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global LNP-mRNA Therapy Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. LNP-mRNA Therapy Report Years Considered

Figure 12. Global LNP-mRNA Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global LNP-mRNA Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global LNP-mRNA Therapy Market Share by Region: 2024 VS 2031

Figure 15. Global LNP-mRNA Therapy Market Share by Players in 2024

Figure 16. Global LNP-mRNA Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by LNP-mRNA Therapy Revenue in 2024

Figure 18. North America LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America LNP-mRNA Therapy Market Share by Country (2020-2031)

Figure 20. United States LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe LNP-mRNA Therapy Market Share by Country (2020-2031)

Figure 24. Germany LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific LNP-mRNA Therapy Market Share by Region (2020-2031)

Figure 32. China LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America LNP-mRNA Therapy Market Share by Country (2020-2031)

Figure 40. Mexico LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa LNP-mRNA Therapy Market Share by Country (2020-2031)

Figure 44. Turkey LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE LNP-mRNA Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Genevant Sciences Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)

Figure 48. Moderna Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)

Figure 49. BioNTech Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)

Figure 50. Pfizer Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)

Figure 51. NanoVation Therapeutics Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)

Figure 52. CureVac Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)

Figure 53. Sanofi Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)

Figure 54. Promab Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)

Figure 55. Grand Pharm Revenue Growth Rate in LNP-mRNA Therapy Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Lipid Nanoparticle LNP Production Equipment Market Research Report 2024

Global Lipid Nanoparticle LNP Formulation Service Market Research Report 2025

Global Lipid Nanoparticle LNP Formulation Market Research Report 2024

Global mRNA Delivery System Market Research Report 2024

Global Lipid Nanoparticle LNP Synthesis Services Market Research Report 2025

Global Lipid Nanoparticle LNP Development Service Market Research Report 2025

Global Lipid Nanoparticles LNP Market Research Report 2024

Global Lipid Nanoparticle LNP Services Market Research Report 2025

Global RNA LNP Lipid Nanoparticle Formulation Market Research Report 2024

Global mRNA Vaccines Therapeutics Market Research Report 2024

Global mRNA Therapy Market Research Report 2024

Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030

Global Lipid Nanoparticle LNP Raw Material Market Research Report 2024

Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030

Global mRNA Treatment Market Research Report 2024

Global Lipid Nanoparticle CDMO Market Research Report 2025

Global Personalized mRNA Cancer Vaccine Therapy Market Research Report 2025

Global Lipid Contract Manufacturing Market Research Report 2024

Global Nanoparticle Drug Delivery Systems Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions